Published online before print August 19, 2002, doi: 10.1161/01.CIR.0000027583.73268.E7
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:1288.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy
From the Departments of Internal Medicine (Y.W., R.Z., I.D., R.T., D.M.R., M.E.A.), Pediatrics (J.T.), Pharmacology (W.Z., D.M.R., M.E.A.), and Molecular Physiology and Biophysics (R.J.C.), Vanderbilt University, Nashville, Tenn, and Department of Molecular Biology (R.P., E.N.O.), The University of Texas Southwestern Medical Center at Dallas, Tex.
Correspondence to Mark E. Anderson, MD, PhD, Division of Cardiovascular Medicine, 383 Preston Research Building, 2220 Pierce Ave, Nashville, TN 37232-6300. E-mail mark.anderson{at}vanderbilt.edu
Background— Calmodulin kinase (CaMK) II is linked to arrhythmia mechanisms in cellular models where repolarization is prolonged. CaMKII upregulation and prolonged repolarization are general features of cardiomyopathy, but the role of CaMKII in arrhythmias in cardiomyopathy is unknown.
Methods and Results— We studied a mouse model of cardiac hypertrophy attributable to transgenic (TG) overexpression of a constitutively active form of CaMKIV that also has increased endogenous CaMKII activity. ECG-telemetered TG mice had significantly more arrhythmias than wild-type (WT) littermate controls at baseline, and arrhythmias were additionally increased by isoproterenol. Arrhythmias were significantly suppressed by an inhibitory agent targeting endogenous CaMKII. TG mice had longer QT intervals and action potential durations than WT mice, and TG cardiomyocytes had frequent early afterdepolarizations (EADs), a hypothesized mechanism for triggering arrhythmias. EADs were absent in WT cells before and after isoproterenol, whereas EAD frequency was unaffected by isoproterenol in TG mice. L-type Ca2+ channels (LTTCs) can activate EADs, and LTCC opening probability (Po) was significantly higher in TG than WT cardiomyocytes before and after isoproterenol. A CaMKII inhibitory peptide equalized TG and WT LTCC Po and eliminated EADs, whereas a peptide antagonist of the Na+/Ca2+ exchanger current, also hypothesized to support EADs, was ineffective.
Conclusions— These findings support the hypothesis that CaMKII is a proarrhythmic signaling molecule in cardiac hypertrophy in vivo. Cellular studies point to EADs as a triggering mechanism for arrhythmias but suggest that the increase in arrhythmias after ß-adrenergic stimulation is independent of enhanced EAD frequency.
Key Words: arrhythmia • calcium • signal transduction
This article has been cited by other articles:
 |
|
 |
|
  L. F. Couchonnal and M. E. Anderson The Role of Calmodulin Kinase II in Myocardial Physiology and Disease Physiology, June 1, 2008; 23(3): 151 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bito, F. R. Heinzel, L. Biesmans, G. Antoons, and K. R. Sipido Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling Cardiovasc Res, January 15, 2008; 77(2): 315 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Grandi, J. L. Puglisi, S. Wagner, L. S. Maier, S. Severi, and D. M. Bers Simulation of Ca-Calmodulin-Dependent Protein Kinase II on Rabbit Ventricular Myocyte Ion Currents and Action Potentials Biophys. J., December 1, 2007; 93(11): 3835 - 3847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Fabritz Drug-induced torsades de pointes -- A form of mechano-electric feedback? Cardiovasc Res, November 1, 2007; 76(2): 202 - 203. [Full Text] [PDF]
|
|
|
|
|
|
L. S. Maier and D. M. Bers Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart Cardiovasc Res, March 1, 2007; 73(4): 631 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Anderson Multiple downstream proarrhythmic targets for calmodulin kinase II: Moving beyond an ion channel-centric focus Cardiovasc Res, March 1, 2007; 73(4): 657 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, C. Marionneau, R. Zhang, V. Shah, J. W. Hell, J. M. Nerbonne, and M. E. Anderson Calmodulin Kinase II Inhibition Shortens Action Potential Duration by Upregulation of K+ Currents Circ. Res., November 10, 2006; 99(10): 1092 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Zaloga, K. A. Harvey, W. Stillwell, and R. Siddiqui Trans Fatty Acids and Coronary Heart Disease Nutr Clin Pract, October 1, 2006; 21(5): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S.C. Khoo, J. Li, M. V. Singh, Y. Yang, P. Kannankeril, Y. Wu, C. E. Grueter, X. Guan, C. V. Oddis, R. Zhang, et al. Death, Cardiac Dysfunction, and Arrhythmias Are Increased by Calmodulin Kinase II in Calcineurin Cardiomyopathy Circulation, September 26, 2006; 114(13): 1352 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Kannankeril, B. M. Mitchell, S. A. Goonasekera, M. G. Chelu, W. Zhang, S. Sood, D. L. Kearney, C. I. Danila, M. De Biasi, X. H. T. Wehrens, et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy PNAS, August 8, 2006; 103(32): 12179 - 12184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Litwin "Ryanogate": Who Leaked the Calcium? Circ. Res., February 3, 2006; 98(2): 165 - 168. [Full Text] [PDF]
|
|
|
|
|
|
M. Kohlhaas, T. Zhang, T. Seidler, D. Zibrova, N. Dybkova, A. Steen, S. Wagner, L. Chen, J. Heller Brown, D. M. Bers, et al. Increased Sarcoplasmic Reticulum Calcium Leak but Unaltered Contractility by Acute CaMKII Overexpression in Isolated Rabbit Cardiac Myocytes Circ. Res., February 3, 2006; 98(2): 235 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Anderson The Fire From Within: The Biggest Ca2+ Channel Erupts and Dribbles Circ. Res., December 9, 2005; 97(12): 1213 - 1215. [Full Text] [PDF]
|
|
|
|
|
|
X. Ai, J. W. Curran, T. R. Shannon, D. M. Bers, and S. M. Pogwizd Ca2+/Calmodulin-Dependent Protein Kinase Modulates Cardiac Ryanodine Receptor Phosphorylation and Sarcoplasmic Reticulum Ca2+ Leak in Heart Failure Circ. Res., December 9, 2005; 97(12): 1314 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rubio, I. Bodi, G. A. Fuller-Bicer, H. S. Hahn, M. Periasamy, and A. Schwartz Sarcoplasmic Reticulum Adenosine Triphosphatase Overexpression in the L-type Ca2+ Channel Mouse Results in Cardiomyopathy and Ca2+-Induced Arrhythmogenesis Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4): 235 - 249. [Abstract] [PDF]
|
|
|
|
 |
|
 A. L. Mora, J. LaVoy, M. McKean, A. Stecenko, K. L. Brigham, R. Parker, and M. Rojas Prevention of NF-{kappa}B activation in vivo by a cell-permeable NF-{kappa}B inhibitor peptide Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L536 - L544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Tanskanen, J. L. Greenstein, B. O'Rourke, and R. L. Winslow The Role of Stochastic and Modal Gating of Cardiac L-Type Ca2+ Channels on Early After-Depolarizations Biophys. J., January 1, 2005; 88(1): 85 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Zhang and J. H. Brown Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure Cardiovasc Res, August 15, 2004; 63(3): 476 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. GREENSTEIN, A. J. TANSKANEN, and R. L. WINSLOW Modeling the Actions of {beta}-Adrenergic Signaling on Excitation--Contraction Coupling Processes Ann. N.Y. Acad. Sci., May 1, 2004; 1015(1): 16 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang and J. I. Goldhaber Return of calcium: Manipulating intracellular calcium to prevent cardiac pathologies PNAS, April 20, 2004; 101(16): 5697 - 5698. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Zhang, S. Miyamoto, and J. H. Brown Cardiomyocyte Calcium and Calcium/Calmodulin-dependent Protein Kinase II: Friends or Foes? Recent Prog. Horm. Res., January 1, 2004; 59(1): 141 - 168. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Wu, J. T. Kimbrough, R. J. Colbran, and M. E. Anderson Calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes J. Physiol., January 1, 2004; 554(1): 145 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Roden A Surprising New Arrhythmia Mechanism in Heart Failure Circ. Res., October 3, 2003; 93(7): 589 - 591. [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Maguire, H. Wakimoto, V. V. Patel, P. E. Hammer, K. Gauvreau, and C. I. Berul Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies Physiol Genomics, September 29, 2003; 15(1): 84 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bodi, J. N. Muth, H. S. Hahn, N. N. Petrashevskaya, M. Rubio, S. E. Koch, G. Varadi, and A. Schwartz Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure: Complex nature of k+ current changes and action potential duration J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1611 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Knollmann, P. Kirchhof, S. G. Sirenko, H. Degen, A. E. Greene, T. Schober, J. C. Mackow, L. Fabritz, J. D. Potter, and M. Morad Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling Circ. Res., March 7, 2003; 92(4): 428 - 436. [Abstract] [Full Text] [PDF]
|
|